TRIA is First Entry to Home-Based Device Market Featuring Diode Laser
Technology for Hair Removal
PLEASANTON, Calif., Feb. 7 /PRNewswire/ -- SpectraGenics, a leader in light-based therapeutic beauty devices, today announced over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for their patented hand-held laser hair removal device designed for at-home use. The TRIA is the first hair removal laser to enter the U.S. home-based device market, an industry projected to grow exponentially over the next three years.
"The FDA clearance is the culmination of many years of research, clinical testing and innovative product design efforts," said Robert Grove, PhD, CEO, SpectraGenics. "Our engineers are the same scientists who developed the first and gold-standard professional diode laser hair removal system over 10 years ago which is still used by physicians nationwide. We've invested significant resources to harness that same light-based technology to deliver a safe, effective way for consumers to treat unwanted hair in the privacy of their homes."
The TRIA device is the first at-home device to feature a diode laser specially designed to be safe and effective for at-home use. SpectraGenics has been selling a version of the TRIA, called i-Epi, in Japan since 2005. The TRIA is the first in a series of at-home science-based beauty devices to be pioneered by SpectraGenics.
"I have been performing laser hair removal in my office for 12 years and welcome the arrival of TRIA as an adjunct to professional laser hair removal," said Eric F. Bernstein, MD, Clinical Associate Professor at the University of Pennsylvania. "TRIA is simple, safe and very effective. Many of my patients will be able to use TRIA for touch-ups in between visits as well as on other areas not treated in-office to achieve and maintain beautiful results, and I expect it to increase the number of patients I see for laser hair removal. The TRIA was developed by the engineers who created the diode hair removal laser I use in my office today."
Professional laser hair removal is consistently the leading non-surgical cosmetic treatment for women 34 years and under, and the second most popular procedure for women over 35, according to the American Society for Aesthetic Plastic Surgery. The at-home device market is relatively new and expected to grow exponentially with the introduction of products targeted for treatment of hair, acne, wrinkles and skin rejuvenation.
TRIA will be available Spring 2008 from medical professionals and select retailers, as well as online at http://www.triabeauty.com.
SpectraGenics, Inc., the leader in light-based therapeutic beauty devices, gives men and women the freedom to incorporate clinically-proven aesthetic technologies into their personal care regimen. In 1993 Robert Grove, Ph.D., and a team of American dermatologists and engineers developed the first diode laser for hair removal utilized by physicians in their medical practices. In 2003, these individuals founded SpectraGenics, Inc. and assembled an internationally renowned team of experts in the field of aesthetic lasers to begin the development of its flagship TRIA device and future innovations in science-driven consumer beauty products.
|SOURCE SpectraGenics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved